The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF)

On Behalf Of The Homes-Hf Study Investigators

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Home telemonitoring is becoming more important to home medical care for patients with heart failure. Since there are no data on home telemonitoring for Japanese patients with heart failure, we investigated its effect on cardiovascular outcomes. The HOMES-HF study was the first multicenter, open-label, randomized, controlled trial (RCT) to elucidate the effectiveness of home telemonitoring of physiological data, such as body weight, blood pressure, and pulse rate, for Japanese patients with heart failure (UMIN Clinical Trials Registry 000006839). The primary end-point was a composite of all-cause death or rehospitalization due to worsening heart failure. We analyzed 181 recently hospitalized patients with heart failure who were randomly assigned to a telemonitoring group (n = 90) or a usual care group (n = 91). The mean follow-up period was 15 (range 0–31) months. There was no statistically significant difference in the primary end-point between groups [hazard ratio (HR), 0.95; 95% confidence interval (CI), 0.548–1.648; p = 0.572]. Home telemonitoring for Japanese patients with heart failure was feasible; however, beneficial effects in addition to those of usual care were not demonstrated. Further investigation of more patients with severe heart failure, participation of home medical care providers, and use of a more integrated home telemonitoring system emphasizing communication as well as monitoring of symptoms and physiological data are required.

Original languageEnglish
Pages (from-to)866-876
Number of pages11
JournalHeart and Vessels
Volume33
Issue number8
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Randomized Controlled Trials
Heart Failure
Home Care Services
Physiologic Monitoring
Registries
Cause of Death
Heart Rate
Communication
Body Weight
Clinical Trials
Confidence Intervals
Blood Pressure

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure : home telemonitoring study for patients with heart failure (HOMES-HF). / On Behalf Of The Homes-Hf Study Investigators.

In: Heart and Vessels, Vol. 33, No. 8, 01.08.2018, p. 866-876.

Research output: Contribution to journalArticle

@article{bcb750129a8e41cd9d5a9e1e323835f8,
title = "The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF)",
abstract = "Home telemonitoring is becoming more important to home medical care for patients with heart failure. Since there are no data on home telemonitoring for Japanese patients with heart failure, we investigated its effect on cardiovascular outcomes. The HOMES-HF study was the first multicenter, open-label, randomized, controlled trial (RCT) to elucidate the effectiveness of home telemonitoring of physiological data, such as body weight, blood pressure, and pulse rate, for Japanese patients with heart failure (UMIN Clinical Trials Registry 000006839). The primary end-point was a composite of all-cause death or rehospitalization due to worsening heart failure. We analyzed 181 recently hospitalized patients with heart failure who were randomly assigned to a telemonitoring group (n = 90) or a usual care group (n = 91). The mean follow-up period was 15 (range 0–31) months. There was no statistically significant difference in the primary end-point between groups [hazard ratio (HR), 0.95; 95{\%} confidence interval (CI), 0.548–1.648; p = 0.572]. Home telemonitoring for Japanese patients with heart failure was feasible; however, beneficial effects in addition to those of usual care were not demonstrated. Further investigation of more patients with severe heart failure, participation of home medical care providers, and use of a more integrated home telemonitoring system emphasizing communication as well as monitoring of symptoms and physiological data are required.",
author = "{On Behalf Of The Homes-Hf Study Investigators} and Norihiko Kotooka and Masafumi Kitakaze and Kengo Nagashima and Machiko Asaka and Yoshiharu Kinugasa and Kotaro Nochioka and Atsushi Mizuno and Daisuke Nagatomo and Daigo Mine and Yoko Yamada and Akiko Kuratomi and Norihiro Okada and Daisuke Fujimatsu and So Kuwahata and Shigeru Toyoda and Hirotani, {Shin ichi} and Takahiro Komori and Kazuo Eguchi and Kazuomi Kario and Takayuki Inomata and Kaoru Sugi and Kazuhiro Yamamoto and Hiroyuki Tsutsui and Tohru Masuyama and Hiroyuki Tsutsui and Momomura, {Shin ichi} and Yoshihiko Seino and Yasunori Sato and Teruo Inoue and Koichi Node and Mika Nakamizo and Chika Nishiyama and Kikumi Morita and Yuko Horiuchi and Michiko Hanawa and Takako Kanai and Hideki Hanaoka and Tohru Izumi and Yoshihiko Saito and Yukihito Sato and A. Haruyama and S. Inami and Y. Nishi and A. Amano and T. Arikawa and M. Kikuchi and Y. Eto and K. Ishii and K. Fukuda and Ken-Ichi Yamada",
year = "2018",
month = "8",
day = "1",
doi = "10.1007/s00380-018-1133-5",
language = "English",
volume = "33",
pages = "866--876",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "8",

}

TY - JOUR

T1 - The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure

T2 - home telemonitoring study for patients with heart failure (HOMES-HF)

AU - On Behalf Of The Homes-Hf Study Investigators

AU - Kotooka, Norihiko

AU - Kitakaze, Masafumi

AU - Nagashima, Kengo

AU - Asaka, Machiko

AU - Kinugasa, Yoshiharu

AU - Nochioka, Kotaro

AU - Mizuno, Atsushi

AU - Nagatomo, Daisuke

AU - Mine, Daigo

AU - Yamada, Yoko

AU - Kuratomi, Akiko

AU - Okada, Norihiro

AU - Fujimatsu, Daisuke

AU - Kuwahata, So

AU - Toyoda, Shigeru

AU - Hirotani, Shin ichi

AU - Komori, Takahiro

AU - Eguchi, Kazuo

AU - Kario, Kazuomi

AU - Inomata, Takayuki

AU - Sugi, Kaoru

AU - Yamamoto, Kazuhiro

AU - Tsutsui, Hiroyuki

AU - Masuyama, Tohru

AU - Tsutsui, Hiroyuki

AU - Momomura, Shin ichi

AU - Seino, Yoshihiko

AU - Sato, Yasunori

AU - Inoue, Teruo

AU - Node, Koichi

AU - Nakamizo, Mika

AU - Nishiyama, Chika

AU - Morita, Kikumi

AU - Horiuchi, Yuko

AU - Hanawa, Michiko

AU - Kanai, Takako

AU - Hanaoka, Hideki

AU - Izumi, Tohru

AU - Saito, Yoshihiko

AU - Sato, Yukihito

AU - Haruyama, A.

AU - Inami, S.

AU - Nishi, Y.

AU - Amano, A.

AU - Arikawa, T.

AU - Kikuchi, M.

AU - Eto, Y.

AU - Ishii, K.

AU - Fukuda, K.

AU - Yamada, Ken-Ichi

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Home telemonitoring is becoming more important to home medical care for patients with heart failure. Since there are no data on home telemonitoring for Japanese patients with heart failure, we investigated its effect on cardiovascular outcomes. The HOMES-HF study was the first multicenter, open-label, randomized, controlled trial (RCT) to elucidate the effectiveness of home telemonitoring of physiological data, such as body weight, blood pressure, and pulse rate, for Japanese patients with heart failure (UMIN Clinical Trials Registry 000006839). The primary end-point was a composite of all-cause death or rehospitalization due to worsening heart failure. We analyzed 181 recently hospitalized patients with heart failure who were randomly assigned to a telemonitoring group (n = 90) or a usual care group (n = 91). The mean follow-up period was 15 (range 0–31) months. There was no statistically significant difference in the primary end-point between groups [hazard ratio (HR), 0.95; 95% confidence interval (CI), 0.548–1.648; p = 0.572]. Home telemonitoring for Japanese patients with heart failure was feasible; however, beneficial effects in addition to those of usual care were not demonstrated. Further investigation of more patients with severe heart failure, participation of home medical care providers, and use of a more integrated home telemonitoring system emphasizing communication as well as monitoring of symptoms and physiological data are required.

AB - Home telemonitoring is becoming more important to home medical care for patients with heart failure. Since there are no data on home telemonitoring for Japanese patients with heart failure, we investigated its effect on cardiovascular outcomes. The HOMES-HF study was the first multicenter, open-label, randomized, controlled trial (RCT) to elucidate the effectiveness of home telemonitoring of physiological data, such as body weight, blood pressure, and pulse rate, for Japanese patients with heart failure (UMIN Clinical Trials Registry 000006839). The primary end-point was a composite of all-cause death or rehospitalization due to worsening heart failure. We analyzed 181 recently hospitalized patients with heart failure who were randomly assigned to a telemonitoring group (n = 90) or a usual care group (n = 91). The mean follow-up period was 15 (range 0–31) months. There was no statistically significant difference in the primary end-point between groups [hazard ratio (HR), 0.95; 95% confidence interval (CI), 0.548–1.648; p = 0.572]. Home telemonitoring for Japanese patients with heart failure was feasible; however, beneficial effects in addition to those of usual care were not demonstrated. Further investigation of more patients with severe heart failure, participation of home medical care providers, and use of a more integrated home telemonitoring system emphasizing communication as well as monitoring of symptoms and physiological data are required.

UR - http://www.scopus.com/inward/record.url?scp=85042097185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042097185&partnerID=8YFLogxK

U2 - 10.1007/s00380-018-1133-5

DO - 10.1007/s00380-018-1133-5

M3 - Article

C2 - 29450689

AN - SCOPUS:85042097185

VL - 33

SP - 866

EP - 876

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 8

ER -